Vulturar, D.-M.; Neag, M.A.; Vesa, Ș.C.; Maierean, A.-D.; Gherman, D.; Buzoianu, A.D.; Orăsan, O.H.; Todea, D.-A.
Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection. Int. J. Mol. Sci. 2022, 23, 14462.
https://doi.org/10.3390/ijms232214462
AMA Style
Vulturar D-M, Neag MA, Vesa ȘC, Maierean A-D, Gherman D, Buzoianu AD, Orăsan OH, Todea D-A.
Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection. International Journal of Molecular Sciences. 2022; 23(22):14462.
https://doi.org/10.3390/ijms232214462
Chicago/Turabian Style
Vulturar, Damiana-Maria, Maria Adriana Neag, Ștefan Cristian Vesa, Anca-Diana Maierean, Diana Gherman, Anca Dana Buzoianu, Olga Hilda Orăsan, and Doina-Adina Todea.
2022. "Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection" International Journal of Molecular Sciences 23, no. 22: 14462.
https://doi.org/10.3390/ijms232214462
APA Style
Vulturar, D.-M., Neag, M. A., Vesa, Ș. C., Maierean, A.-D., Gherman, D., Buzoianu, A. D., Orăsan, O. H., & Todea, D.-A.
(2022). Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection. International Journal of Molecular Sciences, 23(22), 14462.
https://doi.org/10.3390/ijms232214462
_Putnam.png)
